[go: up one dir, main page]

TW200710091A - (1,10B-dihydro-2-(aminoalkyl-phenyl)-5H-pyrazolo [1,5-c][1,3]benzoxazin-5-yl)phenyl methanone derivatives as HIV viral replication inhibitors - Google Patents

(1,10B-dihydro-2-(aminoalkyl-phenyl)-5H-pyrazolo [1,5-c][1,3]benzoxazin-5-yl)phenyl methanone derivatives as HIV viral replication inhibitors

Info

Publication number
TW200710091A
TW200710091A TW095112590A TW95112590A TW200710091A TW 200710091 A TW200710091 A TW 200710091A TW 095112590 A TW095112590 A TW 095112590A TW 95112590 A TW95112590 A TW 95112590A TW 200710091 A TW200710091 A TW 200710091A
Authority
TW
Taiwan
Prior art keywords
phenyl
benzoxazin
pyrazolo
viral replication
present
Prior art date
Application number
TW095112590A
Other languages
English (en)
Inventor
Abdellah Tahri
Li-Li Hu
Dominique Louis Nestor Ghislain Surleraux
Piet Tom Bert Paul Wigerinck
Original Assignee
Tibotec Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tibotec Pharm Ltd filed Critical Tibotec Pharm Ltd
Publication of TW200710091A publication Critical patent/TW200710091A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
TW095112590A 2005-04-11 2006-04-10 (1,10B-dihydro-2-(aminoalkyl-phenyl)-5H-pyrazolo [1,5-c][1,3]benzoxazin-5-yl)phenyl methanone derivatives as HIV viral replication inhibitors TW200710091A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05102847 2005-04-11

Publications (1)

Publication Number Publication Date
TW200710091A true TW200710091A (en) 2007-03-16

Family

ID=35170050

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095112590A TW200710091A (en) 2005-04-11 2006-04-10 (1,10B-dihydro-2-(aminoalkyl-phenyl)-5H-pyrazolo [1,5-c][1,3]benzoxazin-5-yl)phenyl methanone derivatives as HIV viral replication inhibitors

Country Status (11)

Country Link
US (2) US7465727B2 (zh)
EP (1) EP1871777A1 (zh)
JP (1) JP5078874B2 (zh)
CN (1) CN101155816B (zh)
AR (1) AR056652A1 (zh)
AU (1) AU2006233922B2 (zh)
CA (1) CA2604686C (zh)
MX (1) MX2007012630A (zh)
RU (1) RU2416615C2 (zh)
TW (1) TW200710091A (zh)
WO (1) WO2006108828A1 (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY169670A (en) 2003-09-03 2019-05-08 Tibotec Pharm Ltd Combinations of a pyrimidine containing nnrti with rt inhibitors
CL2008000746A1 (es) * 2007-03-14 2008-09-22 Tibotec Pharm Ltd Composicion farmaceutica en solucion que comprende tmc278 y un polimero soluble en agua; proceso de preparacion de dicha composicion; y uso de un polvo que comprende tmc278 para tratar sida.
US7635773B2 (en) 2008-04-28 2009-12-22 Cydex Pharmaceuticals, Inc. Sulfoalkyl ether cyclodextrin compositions
CN101318968A (zh) * 2008-07-18 2008-12-10 青岛黄海制药有限责任公司 一种苯并噁嗪并吡唑类及开环化合物
WO2013123081A2 (en) * 2012-02-14 2013-08-22 Children's Hospital Medical Center Use of small molecule inhibitors targeting the interaction between rac gtpase and p67 (phox)
HUE058834T2 (hu) 2012-02-15 2022-09-28 Cydex Pharmaceuticals Inc Elõállítási eljárás ciklodextrin-származékokhoz
FI3183295T3 (fi) * 2014-08-22 2023-09-25 Cydex Pharmaceuticals Inc Fraktioidut alkyloidut syklodekstriinikoostumukset ja menetelmät niiden valmistamiseksi ja käyttämiseksi

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5145684A (en) 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
DE4210939A1 (de) * 1992-04-02 1993-10-07 Bayer Ag Verwendung von 7-Oxo-7H-pyrido[1,2,3-de][1,4]benzoxacin-6-carbonsäuren und -estern als Arzneimittel
PH30929A (en) 1992-09-03 1997-12-23 Janssen Pharmaceutica Nv Beads having a core coated with an antifungal and a polymer.
JP3732508B2 (ja) 1993-10-01 2006-01-05 アストラ・アクチエボラーグ 粉末状薬剤の製造方法
CN1165291C (zh) 1996-05-20 2004-09-08 詹森药业有限公司 具有改进的生物利用度的抗真菌组合物
ATE248826T1 (de) * 1996-10-02 2003-09-15 Bristol Myers Squibb Pharma Co 4,4-disubstituierte 1,4-dihydro-2h-3,1-benzoxazin-2-one die anwendbar sind als hiv- reverstranskriptase-inhibitoren, zwischenprodukte und verfahren zu ihrer herstellung
PL207590B1 (pl) 1999-09-24 2011-01-31 Janssen Pharmaceutica Nv Cząstka stanowiąca dyspersję stałą oraz postać dawkowania, sposób ich otrzymywania i zastosowanie
AR048650A1 (es) * 2004-05-04 2006-05-10 Tibotec Pharm Ltd Derivados de (1,10b-dihidro-2-(aminocarbonil-fenil)-5h-pirazolo[1,5 c][1,3]benzoxazin-5-il)fenil metanona como inhibidores de la replicacion viral del vih

Also Published As

Publication number Publication date
WO2006108828A1 (en) 2006-10-19
CN101155816A (zh) 2008-04-02
RU2007141639A (ru) 2009-05-20
US7465727B2 (en) 2008-12-16
AU2006233922A1 (en) 2006-10-19
US7745432B2 (en) 2010-06-29
CA2604686C (en) 2014-08-26
RU2416615C2 (ru) 2011-04-20
US20080214534A1 (en) 2008-09-04
US20090048242A1 (en) 2009-02-19
MX2007012630A (es) 2007-11-23
JP5078874B2 (ja) 2012-11-21
EP1871777A1 (en) 2008-01-02
JP2008535894A (ja) 2008-09-04
AU2006233922B2 (en) 2012-05-17
AR056652A1 (es) 2007-10-17
CA2604686A1 (en) 2006-10-19
CN101155816B (zh) 2011-07-27

Similar Documents

Publication Publication Date Title
EP2041159B8 (en) Macrocyclic compounds as antiviral agents
TW200716631A (en) Pyrido[2,3-d]pyrimidines useful as HCV inhibitors, and methods for the preparation thereof
MY146123A (en) Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatment using the same
EA200401436A1 (ru) Ингибиторы протеазы вич для лечения инфекции вич и фармацевтическая композиция
WO2005013892A3 (en) Hydrolytically-resistant boron-containing therapeutics and methods of use
NO20064547L (no) Fremgangsmater for behandling av HIV infeksjon
WO2008127364A3 (en) Antiviral compounds and use thereof
ATE530561T1 (de) 3-ether- und 3-thioether-substituierte ciclosporinderivate zur behandlung und prävention einer hepatitis-c-infektion
WO2007131072A3 (en) Hydrolytically-resistant boron-containing therapeutics and methods of use
NO20081073L (no) Makrocykliske inhibitorer av hepatitt C virus
EP2431379A3 (en) HCV inhibitors
TW200606162A (en) Pyrazolopyridine derivatives
WO2001029037A3 (en) Condensed naphthyridines as hiv reverse transcriptase inhibitors
MX2010002296A (es) Inhibidores iv de polimerasa de fosfadiazina hcv.
TW200710091A (en) (1,10B-dihydro-2-(aminoalkyl-phenyl)-5H-pyrazolo [1,5-c][1,3]benzoxazin-5-yl)phenyl methanone derivatives as HIV viral replication inhibitors
GEP20084452B (en) Sulfonamide derivatives for the treatment of diseases
UA96277C2 (en) Benzimidazole derivatives
WO2009036341A3 (en) Compositions and methods relating to hiv protease inhibition
WO2005041951A3 (en) Rhodanine derivatives for use as antiviral agents
ATE383345T1 (de) Quinoxalin-3-on-verdindungen als orexin-rezeptor antagonisten.
YU62504A (sh) Triciklična 2-pirimidonska jedinjenja korisna kao inhibitori hiv reverzne transkriptoze
NO20065898L (no) 1-heterocyklyl-1,5-dihydro-pyrido[3,2-b]indol-2-oner
WO2004002410A3 (en) 2,4-disubstituted-pyridine n-oxides useful as hiv reverse transcriptase inhibitors
HK1131988A1 (en) Polycyclic agents for the treatment of respiratory syncytial virus infections
NO20065582L (no) (1,lOB-dihydro-2-(amtnokarbonyl-fenyl)-SH-pyrazolo[1,5-C][1,3]benzoksazin-5-yl)fenylmetanonderivater som HIV-virusreplikasjonsinhibitorer